Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Samsung Electronics | 4.65% | $262.81K | $803.59B | 230.04% | ― | |
| AstraZeneca | 4.65% | $262.64K | $323.92B | 30.42% | 80 Outperform | |
| TSMC | 4.56% | $257.90K | $1.57T | 86.91% | 81 Outperform | |
| SSE | 3.46% | $195.72K | £31.39B | 73.50% | 74 Outperform | |
| Mitsubishi Electric | 3.41% | $192.65K | ¥11.82T | 120.26% | 72 Outperform | |
| BP p.l.c. | 3.20% | $181.09K | £72.19B | 4.49% | 71 Outperform | |
| ― | 3.17% | $179.02K | ― | ― | ― | |
| Ebara | 2.77% | $156.55K | ¥2.62T | 202.83% | 60 Neutral | |
| Unilever | 2.68% | $151.73K | £116.19B | 8.76% | 72 Outperform | |
| Royal Bank Of Canada | 2.67% | $151.14K | $239.18B | 45.08% | 75 Outperform |